We are live on ! Find out more
ALT icon

Altimmune
ALT

71 hedge funds and large institutions have $20.3M invested in Altimmune in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 20

19% less funds holding

Funds holding: 88 → 71 (-17)

57% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 23

77% less capital invested

Capital invested by funds: $90.1M → $20.3M (-$69.8M)

98% less call options, than puts

Call options by funds: $3K | Put options by funds: $146K

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
71
Holders Change
-17
Holders Change %
-19.32%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
26
Reduced
20
Closed
23
Calls
$3K
Puts
$146K
Net Calls
-$143K
Net Calls Change
-$269K

Top Buyers

1
BlackRock
BlackRock
New York
+$4.92M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.36M
3
FQ
First Quadrant
California
+$2.9M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.57M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.52M

Top Sellers

1
PGCM
Prescott Group Capital Management
Oklahoma
-$10.6M
2
NCM
Nantahala Capital Management
Connecticut
-$10.4M
3
NRCM
Northern Right Capital Management
Connecticut
-$4.32M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.61M
5
TC
TFS Capital
Pennsylvania
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
76
Squarepoint
New York
– -$362K -371 Closed
Invesco
77
Invesco
Georgia
– -$320K -329 Closed
CS
78
Credit Suisse
Switzerland
– -$256K -263 Closed
AIM
79
Acrospire Investment Management
Illinois
– -$189K -194 Closed
TSS
80
Two Sigma Securities
New York
– -$181K -186 Closed
Millennium Management
81
Millennium Management
New York
– -$173K -177 Closed
Wellington Management Group
82
Wellington Management Group
Massachusetts
– -$156K -160 Closed
Two Sigma Advisers
83
Two Sigma Advisers
New York
– -$112K -115 Closed
TCM
84
Teza Capital Management
Illinois
– -$110K -113 Closed
BGIM
85
Brandywine Global Investment Management
Pennsylvania
– -$108K -110 Closed
CSS
86
Cubist Systematic Strategies
Connecticut
– -$102K -104 Closed
RFCA
87
R&F Capital Advisors
New York
– -$74K -76 Closed
Simplex Trading
88
Simplex Trading
Illinois
– -$39.6K -74 -95%
Allianz Asset Management
89
Allianz Asset Management
Germany
– -$53K -54 Closed
Mackenzie Financial
90
Mackenzie Financial
Ontario, Canada
– -$49K -50 Closed
Bank of Montreal
91
Bank of Montreal
Ontario, Canada
– -$20.9K -39 -98%
HSBC Holdings
92
HSBC Holdings
United Kingdom
– -$35K -36 Closed
ProShare Advisors
93
ProShare Advisors
Maryland
– -$33K -33 Closed
LTFS
94
Ladenburg Thalmann Financial Services
Florida
– -$13.4K -25 -96%
1 2 3
4

ALT Hedge Fund Activity: Q1 2017 in Review

71 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2017, worth a combined $20.3M — down 77% from $90.1M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ALT and 10 opened new positions — a net loss of 13 holders — while 20 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $4.92M. The largest seller was Prescott Group Capital Management, exiting entirely with an estimated $10.6M sold.

  • 71 institutional investors held Altimmune (ALT) as of Q1 2017, down from 88 in Q4 2016.
  • Funds reported $20.3M of Altimmune stock for Q1 2017, down 77% quarter-over-quarter.
  • 10 funds opened new Altimmune positions in Q1 2017 and 23 closed out, a net change of -13 holders.
  • The largest Altimmune buyer in Q1 2017 was BlackRock, an estimated $4.92M added.
  • The largest Altimmune seller in Q1 2017 was Prescott Group Capital Management, an estimated $10.6M sold.

Based on aggregated 13F filings for Q1 2017.